<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/227492-herbal-composition-for-treatment-of-oligospermia-and-to-increase-spermmotility by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 07:17:36 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 227492:HERBAL COMPOSITION FOR TREATMENT OF OLIGOSPERMIA AND TO INCREASE SPERMMOTILITY</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">HERBAL COMPOSITION FOR TREATMENT OF OLIGOSPERMIA AND TO INCREASE SPERMMOTILITY</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>ABSTRACT The invention relates to the mixture of seven herbal alcoholic extracts and three herbal fine powder to treat Oligospermia and related disorders. The extracts and powders were mixed in different ratio to make different compositions of 500 mg in each capsules. The composition containing alcoholic extracts of Withania somnifera (75 mg), Pueraria tuborusa (40 mg), Asparagus racemosus (50 mg), Mucuna pruriens (160 mg), Tribulus terrestris (30 mg) and Trychospermum ammi (30 mg), Chlorophytum arundinaceum (50 mg), and three directly fine powdered herbs, Shelajit (30 mg), Crocus sativus (10 mg), Myristica fragrans (25 mg), when orally feeded to rats in a calculated doses (16.67 mg) showed promising activity without side effects. The same composition on human volunteers (500 mg in capsule, 2 capsules/day) was found to increase the sperm count and motility, while reduces the percentage of abnormal sperms. 16</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>FORM 2<br>
THE PATENT ACT 1970<br>
(39 OF 1970)<br>
&amp;<br>
THE PATENTS RULES, 2003 PROVISIONAL/COMPLETE SPECIFICATION<br>
(See section 10 and rule 13)<br>
1.	TITLE OF THE INVENTION<br>
Herbal Composition and their use for Oligospermia and to increase sperm motility<br>
2.	APPLICANT(S)<br><br>
Name	Nationality	Address<br>
Sharad Pawar College of Pharmacy		Wanadongri, Hingna Road, Nagpur-441 110(Maharshtra)<br>
1.   PREAMBLE TO HE DESCRIPTION<br>
PROVISIONAL	 COMPLETE<br>
The following specification describes the   The following specification particularly<br>
invention,		 describes the invention and the manner in<br>
	      which it is to be performed.	<br>
2.	DESCRIPTION (Description shall start from next page.)<br>
3.	CLAIMS (not applicable for provisional specification. Claims should start with the preamble-"I/we claim" on separate page)<br>
4.	DATE AND SIGNATURE (to be given at the end of last page of specification)<br>
5.   ABSTRACT OF THE INVENTION (to be given along with complete specification<br>
on separate page)<br>
Note.-<br>
*	Repeat boxes in case of more than one entry.<br>
*	To be signed by the applicants(s) or by authorised registered patent agent.<br>
*	Name of the applicant should be given in full, family name in the beginning.<br>
*	Complete address of the applicant should be given stating the postal index no./ code, state and country.<br>
*	Strike out the column which is/are not applicable.<br>
1<br><br>
Description<br>
Field of the Invention<br>
The invention relates to the herbal compositions containing seven herbal alcoholic extracts and three directly fine powders of herbs and use of such compositions in the patients suffering from Oligospermia, lowered sperm density, diminished motility, impaired sperm forward progressions.<br>
Background of the Invention<br>
Oligospermia, lowered sperm density often is idiopathic but may be associated with decreased spermatogenesis as seen with varicoceles. A sperm density of less than 20 million/mi makes fertility statistically less likely in human. Diminished motility impaired sperm forward progressions are the most common of the isolated abnormal seminal parameters and the earliest abnormality seen with varicoceles.<br>
There is a need for herbal compositions, i.e., a natural, holistic edible composition that will serve to treat Oligospermia and increases sperm motility.<br>
Withania somnifera, Ashwagandha<br>
Withania somnifera also known as Ashwagandha, Indian ginseng or white cherry has been an important herb in the Ayurvedic and indigenous medicinal systems for over 300 Years. Historically, the plant has been used as an aphrodisiac, liver tonic, anti inflammatory agent, astringent, and more recently to treat bronchitis, asthma, ulcers, emaciation, insomnia and senile dementia. Ashwagandha is also used therapeutically as an adoptogen for patients with nervous exhaustion, insomnia and debility due to stress, and an immune stimulant to the patients with low white blood cell counts. ( Altern. Med. Rev. 2004, Jun., 9(2): 211-214).<br>
Decoction of root and methanolic extracts of Withania somnifera have been reported to cure sexual weakness and as an aphrodisiac activity. Withania somnifera is useful in arousing sexual desire ( Billore K.V. and Bhatt G.K., Sachitra Ayurved, 1978, 30 (12): 960-966).<br>
Dose: 3-6 Mashas, 3-6 g (Chunekar, K.C., and Pandey, G.S., Bhavaprakasa Nighantu, Chaukhamba Bharati Academy, Varanasi, 2003, 393).<br>
Asparagus racemosus, Shatavari<br>
It is known as the Indian Female Rejuvenative, Shatavari is helpful for low sex drive, menopause, Post menopausal syndrome, and infertility. It is an herb that is commonly used in the Ayurvedic medicine. One of the well-known major therapeutic potentials of Asparagus racemosus ( Shatavari) is its effect on female reproductive system. It is also used as a general tonic, and as an aphrodisiac. Antioxytocic action of saponin isolated from Asparagus racemosus Wild ( Shatavari) on uterine muscle is confirmed.( Arch Int Pharmmacodyn. Ther. 1969 May, 179(l):121-9.)<br>
2<br><br>
Dose: 2 Tola, 24 g (Chunekar, K.C., and Pandey, G.S., Bhavaprakasa Nighantu, Chaukhamba Bharati Academy, Varanasi, 2003, 392).<br>
Crocus sativus, Saffron<br>
Crocus sativus has hot and dry qualities, stimulant or inebriant depending on dosage, sun dried filaments ingested strengthen the uterus and treats menstrual problems, stimulates sexual desires for women. Essential oil evokes long, distinctive orgasms. In high doses saffron oil is abortive and toxic. (J. Clin. Physiol. 1979, Jan, 35(1): 212-7).<br>
Dose: 2-4 Ratti, 0.26-0.52 g (Chunekar, K.C., and Pandey, G.S., Bhavaprakasa Nighantu, Chaukhamba Bharati Academy, Varanasi, 2003, 235).<br>
Mucuna pruriens, Kaunch Beej<br>
It is a good aphrodisiac and also a nervine tonic. It is used in the treatment of the spermatorrhea diseases of the genitourinary system. (J. Econ. Taxon. Bot, 1992,16(2): 383-390) (J. Econ. Taxon. Bot., 1991,15(3): 677-682)<br>
Dose: 2-6 Mashas, 2-6 g (Chunekar, K.C., and Pandey, G.S., Bhavaprakasa Nighantu, Chaukhamba Bharati Academy, Varanasi, 2003, 357).<br>
Myristica fragrans, Nutmeg<br>
Nutmeg is reported to be an expectorant ,vermifuge,aphrodisiac, and as a nervine used by psychiatrists.it is used in tonic and electuaries and is recommened for the treatment of inflammations of bladder and urinary tract.<br>
In order to explore the sexual function improving effect of Myristica fragrans (nutmeg) and Syzygium aromaticum (clove) an experiment study was conducted in normal male mice.<br>
The extracts (50% ethanolic) of the nutmeg and clove were found to stimulate the mounting behaviour of male mice, and also to significantly increase their mating performance. The drugs were devoid of any conspicuous general short term toxicity.<br>
Dose: 2-8 Ratti, 0.260-1.04 g (Chunekar, K.C., and Pandey, G.S., Bhavaprakasa Nighantu, Chaukhamba Bharati Academy, Varanasi, 2003, 216).<br>
Tribulus terrestris, Gokhru<br>
Apart from its claims for improvement of sexual function in men, the puncturevine plant {Tribulus terrestris:TT) has long been considered as an energizer and vitalizer in the indigenous system of medicine. (J. Altern. Complement. Med., 2003, April 9(2): 257-65)<br>
Tribulus terrestris (TT) has long been used in the traditional Chinese and Indian systems of medicine for the treatment of various aliment and is popularly claimed to improve sexual functions in man. TT extract appears to possess aphrodisiac activity probably due to androgen increasing property of TT.( Life Sci. 2002 Aug 9:71 (12),1385-98.)<br>
10<br>
3<br><br>
Dose: 3-6 Mashas, 3-6 g (Chunekar, K.C., and Pandey, G.S., Bhavaprakasa Nighantu, Chaukhamba Bharati Academy, Varanasi, 2003, 293).<br>
Pueraria tuborusa, Vidarikand<br>
It has a good aphrodisiac.<br>
Dose: '/4  - '/2 Tola, 6-12 g (Chunekar, K.C., and Pandey, G.S., Bhavaprakasa Nighantu, Chaukhamba Bharati Academy, Varanasi, 2003, 388).<br>
Trychospermum ammi, Ajowan<br>
It helps in increasing the sexual desire and acts as a rejuvenator.<br>
Dose: 3-6 Mashas, 3-6 g (Chunekar, K.C., and Pandey, G.S., Bhavaprakasa Nighantu, Chaukhamba Bharati Academy, Varanasi, 2003, 26).<br>
Styrax officinale, Shelajit<br>
It is used as a good aphrodisiac and act as a rejuvenator.<br>
Dose: 50 mg (Chunekar, K.C., and Pandey, G.S., Bhavaprakasa Nighantu, Chaukhamba Bharati Academy, Varanasi, 2003, 612).<br>
Chlorophytum arundinaceum, Safed musali<br>
It is used as a good aphrodisiac and act as a rejuvenator.<br>
Dose: '/2 -1 Tola, 6-12 g (Chunekar, K.C., and Pandey, G.S., Bhavaprakasa Nighantu, Chaukhamba Bharati Academy, Varanasi, 2003, 391).<br>
Object of the Invention.<br>
The object of the invention to provide such herbal composition to the patient who are suffering from Oligospermia and decreased sperm motility, without any undesirable side effects.<br>
Details of the Invention<br>
Herbal raw materials used for the invention are Withania somnifera, Styrax officinale, Crocus sativus, Pueraria tuborusa, Asparagus racemosus, Mucuna pruriens, Tribulus terrestris, Chlorophytum arundinaceum and Myristica fragrans. The materials were identified with the help of Department of Botany, Rashtrasant Tukdoji Maharaj, Nagpur University, Nagpur and were used for the extraction. Except Styrax officinale, Crocus sativus and Myristica fragrans, all the herbs were defatted with petroleum ether (60-80) to remove primary metabolites, fats and oil fractions. After extraction with petroleum ether, the materials were dried at room temperature to remove the traces of petroleum ether. Again the defatted materials were extracted with alcohol (ethanol) using Soxhlet apparatus. After extraction, the liquid extracts were distilled on water bath to remove the solvent (ethanol). The semisolid extracts of Withania somnifera, Asparagus racemosus, Pueraria tuborusa, Mucuna pruriens, Trychospermum ammi, Chlorophytum arundinaceum, Tribulus terrestris were kept in separate container to check their purity. Phytochemical screening and thin layer chromatography was performed and to identify secondary metabolites. Crocus sativus, Styrax officinale and Myristica fragrans were grinded to form a fine powder. Using doses of each extract and fine powder as mentioned in Bhavaprakasa Nighantu, above extracts and fine powders were mixed in different ratio to form different compositions, which were then filled in gelatin capsule.<br>
11<br>
4<br><br>
The doses mentioned in Bhavaprakasa Nighantu for each extract and fine powder are higher in comparison with the compositions. Since our composition are combination of extract and fine powder of similar activity, that reduces the doses of each extract or fine powder to obtain desirable effect in the reduced dosage.<br>
COMPOSITION- I<br>
Each capsules (500 mg) contains<br><br>
Sr. No.	Contents	Dose<br>
1	Withania somnifera	75 mg<br>
2	Styrax officinale	30 mg<br>
3	Crocus sativus	10 mg<br>
4	Pueraria tuborusa	40 mg<br>
5	Asparagus racemosus	50 mg<br>
6	Mucuna pruriens	160 mg<br>
7	Tribulus terrestris	30 mg<br>
8	Trychospermum ammi	30 mg<br>
9	Chlorophytum arundinaceum	50 mg<br>
10	Myristica fragrans	25 mg<br>
COMPOSITION IIEach capsules (500 mg) contains	<br>
Sr. No.	Contents	Dose<br>
1	Withania somnifera	HOmg<br>
2	Styrax officinale	30 mg<br>
3	Crocus sativus	10 mg<br>
4	Pueraria tuborusa	50 mg<br>
5	Asparagus racemosus	75 mg<br>
6	Mucuna pruriens	120 mg<br>
7	Tribulus terrestris	20 mg<br>
8	Trychospermum ammi	20 mg<br>
9	Chlorophytum arundinaceum	40 mg<br>
10	Myristica fragrans	25 mg<br>
COMPOSITION IIIEach capsules (500 mg) contains	<br>
Sr. No.	Contents	Dose<br>
1	Withania somnifera	120 mg<br>
2	Pueraria tuborusa	60 mg<br>
3	Asparagus racemosus	60 mg<br>
4	Mucuna pruriens	175 mg<br>
5	Tribulus terrestris	60 mg<br>
6	Myristica fragrans	25 mg<br>
12<br>
5<br><br>
COMPOSITION IV<br>
Each capsules (500 mg) contains<br>
Sr.No.	Contents	Dose<br>
1	Withania somnifera	150 mg<br>
2	Styrax officinale	25 mg<br>
3	Crocus sativus	5mg<br>
4	Pueraria tuborusa	70 mg<br>
5	Asparagus racemosus	100 mg<br>
6	Trychospermum ammi	50 mg<br>
7	Chlorophytum arundinaceum	lOOmg<br>
COMPOSITION V<br>
Each capsules (500 mg) contains<br>
Sr. No.	Contents	Dose<br>
1	Withania somnifera	150 mg<br>
2	Asparagus racemosus	50 mg<br>
3	Mucuna pruriens	150 mg<br>
4	Tribulus terrestris	50 mg<br>
5	Trychospermum ammi	25 mg<br>
6	Myristica fragrans	75 mg<br>
PHARMACOLOGICAL EVALUATION<br>
Sexual behavior study was done according to the method of Daniel Bitran. The following guidelines were followed in the experiment-<br>
(a)	Males were kept individually but females were kept in groups.<br>
(b)	Training of each male for 15 min. at a time, was done till they elicited sexual behaviour. Once the behaviour was noticed, males were exposed to receptive females.<br>
(c)	Repeated training was given to overcome the lack of sexual response in the presence of observers.<br>
(d)	The experiment was conducted in a dark and silent room.<br>
(e)	Any jerking movements of the mating arena was avoided.<br>
(f)	Sufficient space for animals in the mating arena was provided to enable them to chase each other.<br>
(g)	Cleaning of the mating arena was done after each trial, since the urine trails left by one rat may have marked effects on the behaviour of his successor.<br>
Selection of the male rats<br>
Normal adult males of 90 days age were given training for sexual experience. Males were trained individually with normal adult females in estrous in a transparent arena. Only such males who attempted to mount any female were introduced into the cage were used for subsequent experiments. To provide sexual experience, each male rat was allowed 30 minutes exposure to a stimulus female<br>
13<br>
6<br><br>
in behavioural estrous, several days before testing for copulatory performance. The animals were tested three times over 10 day period for copulatory behaviour and divided into three groups demonstrating comparable copulatory performance. Each group consist of six animals. The first group consists of composition I treated sexually active animals, while the second group consists of composition I treated sexually inactive animals and the third group was kept as control.<br>
Selection of the female rats<br>
Adult female rats of 90 days age were ovariectomised. They were allowed to recover from the effect of operation for 10 days. These ovariectomised females were divided into three groups. They were housed in a temperature controlled room (22±2°C) Ovariectomisation and confirmation of estrous were carried out according to standard procedure After overiectomisation, the animals were in diestrous stage. To bring them to estrous, they were given 2 µg/kg of estrogen 48 hr. before and 500 µg/kg of progesterone 6 hr. before copulatory test.<br>
Evaluation of the efficacy of compositions<br>
From 2 weeks prior to the screening tests until the end of the study, the rats were housed individually at 22°C under reversed light and dark cycle (with, light from 11.00 pm to 11 am). Food and water were given ad libitum. The composition was made into a suspension with water and administered to male rats orally in the dose of 16.67 mg/kg daily (calculated as per their body weight). Control group received water and food ad libitum. Female ovariectomised rats were given 2 mcg/kg estrogen 48 hr. before the experiment; 500 µg/kg progesterone was also given 6 hr. before the starting of the experiment. Six hours after administration of progesterone, the ovariectomised female rats were observed for estrous stage by observing the vaginal smear of the rat. The female rats which were in estrous stage were employed for the study. The highly receptive female was introduced into male's cage and each male rat was observed for 30 minutes for copulatory behaviour under dim red light. Similar procedure was followed for all groups. The following parameters were recorded (a) Mount frequency: Number of mounts in a series, or number of mounts in a given period of time (30 min). (b) Intromission frequency: Number of intromissions observed in 30 min. (c) Ejaculation frequency: Number of ejaculations in 30 min. (d) Mount latency: Time taken for the first mount from the introduction of the female into male's cage (e) Intromission latency: Time taken for first intromission from the introduction of female into male's cage, (f) weight was recorded on 0, 7th, 14th, 21st and 28th days.<br>
14 7<br><br>
Mounting Frequency<br>
Table A: Effect of composition I on mounting frequency in male albino rats.<br><br>
Group	0Day	7th Day	14th Day	21st Day	28"' Day<br>
1.	4.33+1.10	8.33±1.79	11.6711.89	22.0012.77	28.00+3.92<br>
2.	1.83+0.69	3.33+0.94	6.83+1.21	13.50+2.75	23.0012.83<br>
3.	4.17+1.07	4.3310.74	4.5010.76	5.1711.07	6.0010.81<br>
Values are the mean ± SD, n = 6 in each group.<br>
Mounting Latency<br>
Table B: Effect of composition I on mounting latency in male albino rats.<br>
Group	0Day	7th day	14"1 Day	21st Day	28th Day<br>
1.	315.00118.45	260.00121.14	205.00+22.30	114.67115.69	73.67117.84<br>
2.	493.1717.42	440.50114.30	336.67111.70	278.6719.48	141.8314.34<br>
3.	306.00113.86	302.17+12.59	299.33113.68	294.33113.67	285.33114.84<br>
Values are the mean ± SD, n = 6 in each group.<br>
Intromission Frequency<br>
Table C: Effect of composition I on intromission frequency in male albino rats.<br><br>
Group	0Day	7mDay	14th Day	21st Day	28th day<br>
1.	0	1.1710.37	3.00+1.00	6.0011.15	6.33+1.37<br>
2.	0	0	1.3310.47	3.0010.82	5.83+1.67<br>
3.	0	0	0	0	0<br>
Values are the mean ± SD, n = 6 in each group.<br>
Intromission Latency<br>
Table D: Effect of composition I on intromission latency in male albino rats.<br><br>
Group	0Day	7th Day	14th day	21st Day	28th day<br>
1.	0	504.33136.77	440.00129.27	338.00128.37	245.67+28.28<br>
2.	0	0	592.83113.69	496.00+5.03	336.67111.92<br>
3.	0	0	0	0	0<br>
Values are the mean ± SD, n = 6 in each group.<br>
Ejaculation Frequency<br>
Table E: Effect of composition I on ejaculation frequency in male albino rats.<br><br>
Group	0Day	T Day	14th day	21st Day	28th day<br>
1.	0	0	0.6710.47	0.8310.15	1.00+0.00<br>
2.	0	0	0.6710.47	0.83+0.15	1.0010.00<br>
3.	0	0	0	0	0<br>
Values are the mean ± SD, n = 6 in each group.<br><br>
8<br><br>
15<br><br>
Change in Weight<br>
Table F: Effect of composition I on change in weight in male albino rats.<br><br>
Group	0Day	7th Day	14th day	21* Day	28th day<br>
1.	283.33136.02	288.67+35.67	294.17+35.26	304.17+20.04	306.00+26.97<br>
2.	300.00+42.52	304.83+43.13	310.50+45.57	315.50+32.69	320.33+43.70<br>
3.	296.67±14.04	298.67+14.30	300.00+14.24	302.00+14.61	303.66+14.77<br>
Values are the mean ± SD, n = 6 in each group.<br>
There was significant increase in the mounting frequency while decrease in mounting latency on the 21st day in the composition I treated active and inactive animals. Comparison of 28th day observations with 0 day revealed that control group did not show any change in response.<br>
Considerable increase in the intromission frequency and decrease in intromission latency in the 21st day and 28th day in composition I treated animals (sexually active and inactive).<br>
Ejaculation frequency also increased remarkably on the 21st day and 28th day in case of both sexually active and inactive animals receiving composition I.<br>
Weights of animals receiving composition I increased significantly in the case of sexually active and inactive animals.<br>
Similar experiments were conducted for all the remaining compositions, it was observed that the composition I had promising activity.<br><br>
Photo 1. T.S. of rat testes of control group<br>
After experimentation although they had gained some weight but were more active as compared to control. In histopathology of their testes it was observed that sperm count and semen layers were increased in their seminal vesicles (Photo 1, 2 &amp; 3), it was also observed that the composition had no adverse effect on liver (Photo 4 &amp; 5).<br>
16<br><br>
On the basis of animals studies, human trials was performed on five groups containing six persons in each group suffering from Oligospermia and related disorders. Pre analysis of their semen and physical fitness was done. Groups were made on the basis of sperm count, motility of sperm and abnormal sperm morphology. Group I with sperm count varying below the 20 millions/ml with normal sperm motility and normal sperm morphology. Group II is similar to group I but with sperm count varying between 20-60 millions/ml.<br>
In Group III motility of sperm varying below 70% with normal sperm count and normal sperm morphology, while Group IV is similar to group III but with sperm count varying below the 60 millions/ml with below 70% motility of sperm and abnormal sperm morphology. Group V with abnormal morphology of sperm with normal sperm count and normal motility of sperm.<br>
After a dose of 2 capsules/day for 28 days of composition I again semen analysis were performed and results were noted. Table 1, Table 2, Table 3, Table 4 and Table 5, showed the result of human trials of Group I, Group II, Group III, Group IV and Group V respectively.<br>
Table 1 and Table 2 showed there were significant increase in sperm count and crosses the normal level of sperm count (60 millions/ml) within 28 days. Table 3 shows there were significant increase in the motility of sperm crosses the normal level of motility of sperm (more than 70%). Table 4 shows significant reduction in the abnormality of sperm.<br>
Table 5 comprising of all the problems mentioned in other tables. There was significant increase in sperm count above the normal level, increase in motility of sperm above the normal level and reduction in abnormality of sperm with 28 days treatment.<br>
19<br>
9<br><br>
Table 1 : Sperm count varying below the 20 millions/ml with normal sperm motility of sperm and normal sperm morphology.<br><br>
Group I	Age in Years	Days				Semen Analysis		<br>
			Volume (ml)	Reaction (PH)	Viscosity	Motility (%)	Sperm Count	Morphology	Other cells<br>
A	24	0	2.0	7.5	Decreased	75	98000	Normal	OL<br>
		14	2.5	7.5	Normal	80	35 million/ml	Normal	OL<br>
		28	3.0	7.5	Normal	80	65 million/ml	Normal	OL<br>
B	20	0	2.5	7.5	Decreased	80	5 million/ml	Normal	OL<br>
		14	2.5	7.5	Normal	85	32 million/ml	Normal	OL<br>
		28	2.5	7.5	Normal	90	71 million/ml	Normal	OL<br>
C	25	0	3.0	7.5	Normal	65	5 million/ml	Normal	OL<br>
		14	2.5	7.5	Normal	75	40 million/ml	Normal	OL<br>
		28	2.5	7.5	Normal	50	75 million/ml	Normal	OL<br>
D	24	0	1.5	7.5	Normal	50	1 million/ml	Normal	OL<br>
		14	2.0	7.5	Normal	75	36 million/ml	Normal	OL<br>
		28	2.0	7.5	Normal	85	61 million/ml	Normal	OL<br>
E	26	0	2.0	7.5	Normal	45	1 million/ml	Normal	OL<br>
		14	2.5	7.5	Normal	70	35 million/ml	Normal	OL<br>
		28	2.0	7.5	Normal	75	65 million/ml	Normal	OL<br>
F	27	0	2.0	7.5	Normal	60	2 million/ml	Normal	OL<br>
		14	2.5	7.5	Normal	75	25 million/ml	Normal	OL<br>
		28	2.5	7.5	Normal	75	61 million/ml	Normal	OL<br><br><br><br>
20<br>
10<br><br>
Table 2 : Sperm count varying between 20-60 millions/ml with normal sperm motility of sperm and normal sperm morphology.<br><br>
Group II	Age in Years	Days	Semen Analysis<br>
			Volume (ml)	Reaction (pH)	Viscosity	Motility (%)	Sperm Count (million/ml)	Morphology	Other cells<br>
A	48	0	2.0	7.5	Decreased	75	20	Normal	OL<br>
		14	1.5	7.5	Normal	90	55	Normal	OL<br>
		28	1.5	7.5	Normal	90	75	Normal	OL<br>
B	24	0	1.5	7.5	Normal	65	25	Normal	OL<br>
		14	2.0	7.5	Normal	85	75	Normal	OL<br>
		28	2.5	7.5	Normal	90	80	Normal	OL<br>
C	25	0	3.0	7.5	Normal	70	35	Normal	OL<br>
		14	3.0	7.5	Normal	90	55	Normal	OL<br>
		28	3.0	7.5	Normal	90	80	Normal	OL<br>
D	26	0	2.5	7.5	Normal	60	40	Normal	OL<br>
		14	2.0	7.5	Normal	90	90	Normal	OL<br>
		28	2.0	7.5	Normal	90	90	Normal	OL<br>
E	25	0	2.0	7.5	Normal	65	32	Normal	OL<br>
		14	2.5	7.5	Normal	75	90	Normal	OL<br>
		28	2.5	7.5	Normal	80	90	Normal	OL<br>
F	27	0	3.0	7.5	Normal	80	33	Normal	OL<br>
		14	2.5	7.5	Normal	85	55	Normal	OL<br>
		28	2.5	7.5	Normal	80	80	Normal	OL<br>
OL - Occasional leucocytes<br>
21<br>
11<br><br>
Table 3 : Mobility of sperm varying below 70% with normal sperm count and normal sperm morphology.<br><br>
Group III	Age in Years	Days				Semen Analysis		<br>
			Volume (ml)	Reaction (pH)	Viscosity	Motility (%)	Sperm Count (millions/ml)	Morphology	Other cells<br>
A	25	0	2.5	7.5	Normal	40	40	Normal	OL<br>
		14	2.0	7.5	Normal	60	61	Normal	OL<br>
		28	2.0	7.5	Normal	80	75	Normal	OL<br>
B	25	0	2.5	7.5	Normal	30	61	Normal	OL<br>
		14	3.0	7.5	Normal	50	65	Normal	OL<br>
		28	2.5	7.5	Normal	90	75	Normal	OL<br>
C	24	0	2.5	7.5	Normal	10	90	Normal	OL<br>
		14	3.0	7.5	Normal	75	91	Normal	OL<br>
		28	3.0	7.5	Normal	90	93	Normal	OL<br>
D	24	0	2.0	7.5	Normal	10	85	Normal	OL<br>
		14	2.5	7.5	Normal	65	87	Normal	OL<br>
		28	2.5	7.5	Normal	85	90	Normal	OL<br>
E	27	0	2.5	7.5	Normal	20	65	Normal	OL<br>
		14	3.0	7.5	Normal	60	70	Normal	OL<br>
		28	3.0	7.5	Normal	90	75	Normal	OL<br>
F	26	0	2.0	7.5	Normal	10	60	Normal	OL<br>
		14	2.5	7.5	Normal	75	61	Normal	OL<br>
		28	2.5	7.5	Normal	90	64	Normal	OL<br><br>
22<br>
12<br><br>
Table 4: Sperm count varying below the 60 million/ml with below 70% motility of sperm and abnormal sperm morphology.<br><br>
GroupV	Age in Years	Days	Semen Analysis<br>
			Volume (ml)	Reaction (pH)	Viscosity	Motility (%)	Sperm Count	Morphology (abnormal sperm%)	Other cells<br>
A	25	0	3.0	7.5	Normal	10	98000/ml	16	4-6 LC<br>
		14	2.5	7.5	Normal	75	35 millions/ml	8	OL<br>
		28	2.5	7.5	Normal	90	65 millions/ml	4	OL<br>
B	25	0	2.5	7.5	Normal	40	20 millions/ml	20	OL<br>
		14	3.0	7.5	Normal	60	60 millions/ml	12	OL<br>
		28	3.0	7.5	Normal	90	75 millions/ml	7	OL<br>
C	26	0	3.5	7.5	Normal	40	25 millions/ml	25	7.8<br>
		14	3.0	7.5	Normal	65	55 millions/ml	15	OL<br>
		28	3.0	7.5	Normal	90	90 millions/ml	6	OL<br>
D	26	0	2.0	7.5	Normal	25	50000 /ml	16	OL<br>
		14	2.5	7.5	Normal	55	35 millions/ml	8	OL<br>
		28	2.5	7.5	Normal	70	70 millions/ml	4	OL<br>
E	24	0	3.5	7.5	Normal	10	1 millions/ml	17	5-6 LC<br>
		14	3.0	7.5	Normal	75	25 millions/ml	7	OL<br>
		28	2.5	7.5	Normal	90	75 millions/ml	6	OL<br>
F	26	0	2.0	7.5	Normal	40	15 millions/ml	22	OL<br>
		14	2.5	7.5	Normal	75	60 millions/ml	12	OL<br>
		28	3.0	7.5	Normal	80	90 millions/ml	6	OL<br>
OL - Occasional leucocytes, LC - Leucocyte<br>
23  <br>
Table 5 : Abnormal morphology of sperm with normal sperm count and normal motility sperm.<br><br>
Group IV	Age in Years	Days	Semen Analysis<br>
			Volume (ml)	Reaction (pH)	Viscosity	Motility (%)	Sperm Count (millions /ml)	Morphology (abnormal sperm%)	Other cells<br>
A	31	0	3.0	7.5	Normal	70	90	20	OL<br>
		14	2.5	7.5	Normal	75	90	12	OL<br>
		28	2.5	7.5	Normal	80	90	4	OL<br>
B	30	0	2.0	7.5	Normal	90	61	16	OL<br>
		14	2.5	7.5	Normal	90	64	8	OL<br>
		28	2.5	7.5	Normal	90	65	4	OL<br>
C	30	0	3.0	7.5	Normal	60	70	25	OL<br>
		14	2.0	7.5	Normal	90	75	16	OL<br>
		28	2.5	7.5	Normal	90	80	5	OL<br>
D	30	0	1.5	7.5	Normal	75	80	16	OL<br>
		14	2.0	7.5	Normal	80	81	8	OL<br>
		28	2.5	7.5	Normal	90	84	4	OL<br>
E	32	0	2.5	7.5	Normal	65	70	20	OL<br>
		14	3.0	7.5	Normal	75	70	15	OL<br>
		28	3.0	7.5	Normal	90	70	8	OL<br>
F	31	0	3.5	7.5	Normal	65	90	21	OL<br>
		14	3.0	7.5	Normal	70	91	13	OL<br>
		28	3.5	7.5	Normal	75	92	3	OL<br>
OL - Occasional leucocytes<br><br>
14<br><br>
24<br><br>
Claims<br>
1.	We claim, the herbal extract composition to treat oligospermia in mammals comprising 500 mg of a mixture in a hard gelatin capsule, of seven herb extract and three directly fine powdered material of plant. Among the different compositions, the composition I is useful in treatment of oligospermia, in a dose of 2 capsules/day for human.<br>
2.	We claim, the composition I as in claim 1 shows good aphrodisiac activity wherein the host is a human and non human animal (rats).<br>
3.	We claim, the composition I as in claim 1 increases the quantity of semen in a human.<br>
4.	We claim, there is increase in sperm count by using composition I as in claim 1 wherein the host is a human.<br>
5.	We claim, the composition I as in claim 1 reduces the abnormality of sperms wherein the host is a human.<br>
6.	We claim, the composition I as in claim 1 shows increase in motility of sperms wherein the host is a human.<br>
7.	We claim, by studying the morphology, healthy sperms are produced after treating with composition I as in claim 1 wherein the host is a human and non human animal (rats).<br>
8.	We claim, the composition I as in claim 1 shows increase in the weight wherein the host is a non human animal (rats).<br>
9.	We claim, the composition I as in claim 1 is nontoxic as observed in the transverse section of liver wherein the host is a non human animal (rats).<br>
10.       We claim, the dose of composition I as in claim 1 for claim 2, 7, 8 and 9 is 16.67 mg/day for non human animal (rats), orally.<br><br><br>
ABSTRACT<br>
The invention relates to the mixture of seven herbal alcoholic extracts and three herbal fine powder to treat Oligospermia and related disorders. The extracts and powders were mixed in different ratio to make different compositions of 500 mg in each capsules. The composition containing alcoholic extracts of Withania somnifera (75 mg), Pueraria tuborusa (40 mg), Asparagus racemosus (50 mg), Mucuna pruriens (160 mg), Tribulus terrestris (30 mg) and Trychospermum ammi (30 mg), Chlorophytum arundinaceum (50 mg), and three directly fine powdered herbs, Shelajit (30 mg), Crocus sativus (10 mg), Myristica fragrans (25 mg), when orally feeded to rats in a calculated doses (16.67 mg) showed promising activity without side effects.<br>
The same composition on human volunteers (500 mg in capsule, 2 capsules/day) was found to increase the sperm count and motility, while reduces the percentage of abnormal sperms.<br>
16<br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWFic3RyYWN0KDI2LTUtMjAwNikuZG9j" target="_blank" style="word-wrap:break-word;">811-mum-2006-abstract(26-5-2006).doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWFic3RyYWN0KDI2LTUtMjAwNikucGRm" target="_blank" style="word-wrap:break-word;">811-mum-2006-abstract(26-5-2006).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LUFCU1RSQUNUKEdSQU5URUQpLSg5LTEtMjAwOSkucGRm" target="_blank" style="word-wrap:break-word;">811-MUM-2006-ABSTRACT(GRANTED)-(9-1-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWFic3RyYWN0LmRvYw==" target="_blank" style="word-wrap:break-word;">811-mum-2006-abstract.doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWFic3RyYWN0LnBkZg==" target="_blank" style="word-wrap:break-word;">811-mum-2006-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LUNBTkNFTExFRCBQQUdFUygxNy0xMC0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">811-MUM-2006-CANCELLED PAGES(17-10-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LUNMQUlNUygyNi01LTIwMDYpLnBkZg==" target="_blank" style="word-wrap:break-word;">811-MUM-2006-CLAIMS(26-5-2006).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LUNMQUlNUyhBTUVOREVEKS0oMTctMTAtMjAwOCkucGRm" target="_blank" style="word-wrap:break-word;">811-MUM-2006-CLAIMS(AMENDED)-(17-10-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWNsYWltcyhncmFudGVkKS0oMjYtNS0yMDA2KS5kb2M=" target="_blank" style="word-wrap:break-word;">811-mum-2006-claims(granted)-(26-5-2006).doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWNsYWltcyhncmFudGVkKS0oMjYtNS0yMDA2KS5wZGY=" target="_blank" style="word-wrap:break-word;">811-mum-2006-claims(granted)-(26-5-2006).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LUNMQUlNUyhHUkFOVEVEKS0oOS0xLTIwMDkpLnBkZg==" target="_blank" style="word-wrap:break-word;">811-MUM-2006-CLAIMS(GRANTED)-(9-1-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWNsYWltcy5kb2M=" target="_blank" style="word-wrap:break-word;">811-mum-2006-claims.doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWNsYWltcy5wZGY=" target="_blank" style="word-wrap:break-word;">811-mum-2006-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWNvcnJlc3BvbmRhbmNlLXJlY2VpdmVkLnBkZg==" target="_blank" style="word-wrap:break-word;">811-mum-2006-correspondance-received.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWNvcnJlc3BvbmRlbmNlKDktOS0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">811-mum-2006-correspondence(9-9-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LUNPUlJFU1BPTkRFTkNFKElQTyktKDMtMi0yMDA5KS5wZGY=" target="_blank" style="word-wrap:break-word;">811-MUM-2006-CORRESPONDENCE(IPO)-(3-2-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWNvcnJlc3BvbmRlbmNlKGlwbyktKDktMTEtMjAwOSkucGRm" target="_blank" style="word-wrap:break-word;">811-mum-2006-correspondence(ipo)-(9-11-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWRlc2NyaXB0aW9uIChjb21wbGV0ZSkucGRm" target="_blank" style="word-wrap:break-word;">811-mum-2006-description (complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LURFU0NSSVBUSU9OKENPTVBMRVRFKS0oMjYtNS0yMDA2KS5wZGY=" target="_blank" style="word-wrap:break-word;">811-MUM-2006-DESCRIPTION(COMPLETE)-(26-5-2006).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LURFU0NSSVBUSU9OKEdSQU5URUQpLSg5LTEtMjAwOSkucGRm" target="_blank" style="word-wrap:break-word;">811-MUM-2006-DESCRIPTION(GRANTED)-(9-1-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWRyYXdpbmcoOS05LTIwMDgpLnBkZg==" target="_blank" style="word-wrap:break-word;">811-mum-2006-drawing(9-9-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LURSQVdJTkcoQU1FTkRFRCktKDktOS0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">811-MUM-2006-DRAWING(AMENDED)-(9-9-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LURSQVdJTkcoR1JBTlRFRCktKDktMS0yMDA5KS5wZGY=" target="_blank" style="word-wrap:break-word;">811-MUM-2006-DRAWING(GRANTED)-(9-1-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWZvcm0gMSgyNi01LTIwMDYpLnBkZg==" target="_blank" style="word-wrap:break-word;">811-mum-2006-form 1(26-5-2006).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWZvcm0gMTgoMjItNi0yMDA2KS5wZGY=" target="_blank" style="word-wrap:break-word;">811-mum-2006-form 18(22-6-2006).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LUZPUk0gMihDT01QTEVURSktKDI2LTUtMjAwNikucGRm" target="_blank" style="word-wrap:break-word;">811-MUM-2006-FORM 2(COMPLETE)-(26-5-2006).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWZvcm0gMihncmFudGVkKS0oMjYtNS0yMDA2KS5kb2M=" target="_blank" style="word-wrap:break-word;">811-mum-2006-form 2(granted)-(26-5-2006).doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWZvcm0gMihncmFudGVkKS0oMjYtNS0yMDA2KS5wZGY=" target="_blank" style="word-wrap:break-word;">811-mum-2006-form 2(granted)-(26-5-2006).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LUZPUk0gMihHUkFOVEVEKS0oOS0xLTIwMDkpLnBkZg==" target="_blank" style="word-wrap:break-word;">811-MUM-2006-FORM 2(GRANTED)-(9-1-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LUZPUk0gMihUSVRMRSBQQUdFKS0oMjYtNS0yMDA2KS5wZGY=" target="_blank" style="word-wrap:break-word;">811-MUM-2006-FORM 2(TITLE PAGE)-(26-5-2006).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LUZPUk0gMihUSVRMRSBQQUdFKS0oR1JBTlRFRCktKDktMS0yMDA5KS5wZGY=" target="_blank" style="word-wrap:break-word;">811-MUM-2006-FORM 2(TITLE PAGE)-(GRANTED)-(9-1-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWZvcm0gMygyNi01LTIwMDYpLnBkZg==" target="_blank" style="word-wrap:break-word;">811-mum-2006-form 3(26-5-2006).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWZvcm0gOSgyMi02LTIwMDYpLnBkZg==" target="_blank" style="word-wrap:break-word;">811-mum-2006-form 9(22-6-2006).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWZvcm0tMS5wZGY=" target="_blank" style="word-wrap:break-word;">811-mum-2006-form-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWZvcm0tMi5kb2M=" target="_blank" style="word-wrap:break-word;">811-mum-2006-form-2.doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWZvcm0tMi5wZGY=" target="_blank" style="word-wrap:break-word;">811-mum-2006-form-2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLW11bS0yMDA2LWZvcm0tOS5wZGY=" target="_blank" style="word-wrap:break-word;">811-mum-2006-form-9.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=ODExLU1VTS0yMDA2LVNQRUNJRklDQVRJT04oQU1FTkRFRCktKDktOS0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">811-MUM-2006-SPECIFICATION(AMENDED)-(9-9-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=YWJzdHJhY3QxLmpwZw==" target="_blank" style="word-wrap:break-word;">abstract1.jpg</a></p>
		<br>
		<div class="pull-left">
			<a href="227491-a-method-for-preparing-indan-1-3-dicarboxylic-acid.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="227493-emulsificated-tip-for-oculistic-surgery-particularly-for-phacoemulsification-of-cataract.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>227492</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>811/MUM/2006</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>10/2009</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>06-Mar-2009</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>09-Jan-2009</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>24-May-2006</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>SHARAD PAWAR COLLEGE OF PHARMACY</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>Wanadongri,Hingna Road, Nagpur-441 110 (Maharashtra),India</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>Katolkar Parimal Pradipkumar</td>
											<td>Plot No.77,Kirti Nagar,Trimurty Square, New Nandanwan, Nagpur-440009</td>
										</tr>
										<tr>
											<td>2</td>
											<td>Duragkar Nandakishore Jeevanrao</td>
											<td>Plot NO.45,Shankar Nagar, Nagpur-440 010</td>
										</tr>
										<tr>
											<td>3</td>
											<td>Bhusari Kishore Pandurang</td>
											<td>35,Tilak Nagar, Nagpur-440 010</td>
										</tr>
										<tr>
											<td>4</td>
											<td>Bodele Shishupal Bhanudas</td>
											<td>Q.NO.17/23,Ambedkar Colony, Lashkaribagh,Nagar440 017</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>N/A</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td></td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td></td>
									<td></td>
								    <td>NA</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/227492-herbal-composition-for-treatment-of-oligospermia-and-to-increase-spermmotility by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 07:17:37 GMT -->
</html>
